124 related articles for article (PubMed ID: 8972063)
1. Potency of veterinary rabies vaccines in The Netherlands: a case for continued vigilance.
Rooijakkers EJ; Nieuwenhuijs JH; Vermeulen AA; van Steenis G; Osterhaus AD
Vet Q; 1996 Dec; 18(4):146-50. PubMed ID: 8972063
[TBL] [Abstract][Full Text] [Related]
2. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing.
Rooijakkers EJ; Uittenbogaard JP; Groen J; Osterhaus AD
J Virol Methods; 1996 Apr; 58(1-2):111-9. PubMed ID: 8783156
[TBL] [Abstract][Full Text] [Related]
3. Reduction of the number of mice used for potency testing of human and animal rabies vaccines.
Bruckner L; Palatini M; Ackermann M; Müller HK; Kihm U
Experientia; 1988 Oct; 44(10):853-7. PubMed ID: 3181371
[TBL] [Abstract][Full Text] [Related]
4. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
5. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
6. Effect of strain differences on the potency testing of rabies vaccines in mice.
Blancou J; Aubert MF; Cain E; Selve M; Thraenhart O; Bruckner L
J Biol Stand; 1989 Jul; 17(3):259-66. PubMed ID: 2793877
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay.
Lewis CE; Reising MM; Fry AM; Conrad SK; Siev D; Gatewood DM; Hermann JR
J Virol Methods; 2013 Jun; 190(1-2):49-52. PubMed ID: 23557669
[TBL] [Abstract][Full Text] [Related]
8. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use.
Abhinay G; Dessain S; Srikanth A; Senthilkumar RL; Vidyasagar P; Praveen A; Chandrasekhar Reddy RV; Swapna Reddy E; Rajendra L
Vaccine; 2014 Jan; 32(2):209-13. PubMed ID: 24262315
[TBL] [Abstract][Full Text] [Related]
9. The rabies peripheral challenge test: more accurate determination of vaccine potency.
Wunderli PS; Dreesen DW; Miller TJ; Baer GM
Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
Gamoh K; Shimazaki Y; Senda M; Makie H; Itoh O; Muramatsu M; Hirayama N; Hatakeyama H
J Vet Med Sci; 2003 Jun; 65(6):685-8. PubMed ID: 12867727
[TBL] [Abstract][Full Text] [Related]
11. In vitro potency tests: challenges encountered during method development.
Yomayuza CL; Thiel HJ; König M
Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
[TBL] [Abstract][Full Text] [Related]
12. Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
Morgeaux S; Poirier B; Ragan CI; Wilkinson D; Arabin U; Guinet-Morlot F; Levis R; Meyer H; Riou P; Shaid S; Volokhov D; Tordo N; Chapsal JM
Vaccine; 2017 Feb; 35(6):966-971. PubMed ID: 28081969
[TBL] [Abstract][Full Text] [Related]
13. In Vitro ELISA Test to Evaluate Rabies Vaccine Potency.
Jallet C; Tordo N
J Vis Exp; 2020 May; (159):. PubMed ID: 32449742
[TBL] [Abstract][Full Text] [Related]
14. [Rabies control should be done from their origin].
Tang Q; Yu YX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):1 p preceding table of contents. PubMed ID: 19031689
[No Abstract] [Full Text] [Related]
15. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody.
Perrin P; Morgeaux S; Sureau P
Biologicals; 1990 Oct; 18(4):321-30. PubMed ID: 2285504
[TBL] [Abstract][Full Text] [Related]
16. A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies.
Ferguson M; Schild GC
J Gen Virol; 1982 Mar; 59(Pt 1):197-201. PubMed ID: 6802936
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
[TBL] [Abstract][Full Text] [Related]
18. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
Ferguson M; Seagroatt V; Schild GC
Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
[TBL] [Abstract][Full Text] [Related]
19. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.
Lafon M; Bourhy H; Sureau P
Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007
[TBL] [Abstract][Full Text] [Related]
20. Effect of the contents and form of rabies glycoprotein on the potency of rabies vaccination in cattle.
Piza AT; Pieri KM; Lusa GM; Caporale GM; Terreran MT; Machado LA; Zanetti CR
Mem Inst Oswaldo Cruz; 2002 Mar; 97(2):265-8. PubMed ID: 12016455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]